Craniosynostosis is a congenital anomaly that can occur as an isolated condition or as part of a syndrome. Although several genes are known to cause syndromic craniosynostosis, only 24% can be attributed to known genes. Therefore, it is likely that more mutations and other genes are involved. We present the identification of a novel point mutation in fibroblast growth factor receptor 2 (FGFR2), c.812G>T, p.(Gly271Val) or c.1851G>C, p.(Leu617Phe). Furthermore, we describe a mutation that has been identified just recently, c.812G>T, (p.Gly271Val) or c.1851G>C, (p.Leu617Phe). In addition, we describe findings from a sequence analysis of all coding exons and exon/intron boundaries of FGFR2 performed on 124 patients with syndromic craniosynostosis.

, , ,,
American Journal of Medical Genetics. Part A
Department of Plastic and Reconstructive Surgery

Goos, J., van den Ouweland, A., Swagemakers, S., Verkerk, A., Hoogeboom, J., van Veelen-Vincent, M.-L., … van der Spek, P. (2015). A novel mutation in FGFR2. American Journal of Medical Genetics. Part A, 167(1), 123–127. doi:10.1002/ajmg.a.36827